Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases

Publisher： Karger

E-ISSN： 1662-6575|8|1|72-77

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.8, Iss.1, 2015-02, pp. : 72-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)

By  

Oncology, Vol. 91, Iss. 1, 2016-05 ,pp. : 24-30

Karger

Access to resources Recommend Favorite

Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-01 ,pp. : 16-18

Karger

Access to resources Recommend Favorite

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 479-480

Karger

Access to resources Recommend Favorite

A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-01 ,pp. : 81-85

Karger

Access to resources Recommend Favorite

Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 311-316

Karger

Access to resources Recommend Favorite